D. E. Shaw & Co., Inc. Nektar Therapeutics Put Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $972,325 - $2.09 Million	-57,500 Reduced 76.67%	17,500 $319,000
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $1.18 Million - $2.2 Million	38,800 Added 107.18%	75,000 $2.47 Million
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $231,250 - $522,250	-5,000 Reduced 12.14%	36,200 $1.77 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $1.5 Million - $2.84 Million	26,200 Added 174.67%	41,200 $4.38 Million
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $345,300 - $907,500	15,000	15,000 $896,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $232M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.